Topical Atropine Induced Acute Psychosis - A case report.

IF 0.2 Q4 OPHTHALMOLOGY
Rabindra Singh Thakuri, Deepak Dhakal, Sagar Tiwari, Polina Dahal, Kaushal Pokhrel, Sanjeeb Bhandari
{"title":"Topical Atropine Induced Acute Psychosis - A case report.","authors":"Rabindra Singh Thakuri, Deepak Dhakal, Sagar Tiwari, Polina Dahal, Kaushal Pokhrel, Sanjeeb Bhandari","doi":"10.3126/nepjoph.v16i1.76997","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Atropine, an anticholinergic agent is widely used topical agent in ophthalmology practice. We present a case report on central anticholinergic syndrome in a patient receiving topical atropine. Case and observation: An eighty-two years old female who had received a penetrating keratoplasty five years ago in the left eye for non-healing corneal ulcer which had failed within 6 months presented with long standing pain in the eye. She was on topical carboxymethylcellulose 1% and moxifloxacin since the last two weeks and was against the advice for evisceration. We used 1% atropine sulphate eyedrops thrice daily for persistent pain of the left eye. Three days after using topical atropine, she developed acute psychomotor agitation, disorientation, confusion and lack of insight with visual hallucination and lowered level of consciousness. These symptoms resolved after cessation of topical atropine and reappeared on its use. A single dose rechallenge under the supervision of a psychiatrist confirmed that the acute psychosis was induced by topical atropine. The reaction was definite according to Naranjo's algorithm.</p><p><strong>Conclusion: </strong>The present case shows that a patient on topical atropine can experience central nervous system side effects seen with systemic absorption. The possibilities of such side effects warrants discussion in patients receiving the medication in routine ophthalmology practice.</p>","PeriodicalId":44759,"journal":{"name":"Nepalese Journal of Ophthalmology","volume":"16 31","pages":"98-102"},"PeriodicalIF":0.2000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nepalese Journal of Ophthalmology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3126/nepjoph.v16i1.76997","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Atropine, an anticholinergic agent is widely used topical agent in ophthalmology practice. We present a case report on central anticholinergic syndrome in a patient receiving topical atropine. Case and observation: An eighty-two years old female who had received a penetrating keratoplasty five years ago in the left eye for non-healing corneal ulcer which had failed within 6 months presented with long standing pain in the eye. She was on topical carboxymethylcellulose 1% and moxifloxacin since the last two weeks and was against the advice for evisceration. We used 1% atropine sulphate eyedrops thrice daily for persistent pain of the left eye. Three days after using topical atropine, she developed acute psychomotor agitation, disorientation, confusion and lack of insight with visual hallucination and lowered level of consciousness. These symptoms resolved after cessation of topical atropine and reappeared on its use. A single dose rechallenge under the supervision of a psychiatrist confirmed that the acute psychosis was induced by topical atropine. The reaction was definite according to Naranjo's algorithm.

Conclusion: The present case shows that a patient on topical atropine can experience central nervous system side effects seen with systemic absorption. The possibilities of such side effects warrants discussion in patients receiving the medication in routine ophthalmology practice.

局部阿托品致急性精神病1例。
简介:阿托品是一种抗胆碱能药物,是眼科广泛使用的外用药物。我们提出一个病例报告中央抗胆碱能综合征的病人接受局部阿托品。病例与观察:一名八十二岁女性,五年前因角膜溃疡不愈合接受穿透性角膜移植术,6个月后失效,眼部长期疼痛。过去两周以来,她一直在局部使用1%羧甲基纤维素和莫西沙星,并反对摘除内脏的建议。我们使用1%硫酸阿托品滴眼液治疗左眼持续疼痛,每日三次。局部使用阿托品3天后,患者出现急性精神运动性躁动、定向障碍、思维混乱和缺乏洞察力,伴视幻觉和意识水平降低。这些症状在局部停止使用阿托品后消失,并在使用后再次出现。在精神科医生的监督下,单剂量再挑战证实急性精神病是由局部阿托品引起的。根据纳兰霍的算法,这种反应是确定的。结论:本病例表明,局部使用阿托品的患者可出现全身吸收的中枢神经系统副作用。这些副作用的可能性值得在常规眼科实践中对接受药物治疗的患者进行讨论。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
27
审稿时长
12 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信